🔗 Share this article

An underground market for unapproved weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these profiles privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the UK is worrisome and could result in users administering products of uncertain source.

Some professionals stated the demand for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Several content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and customer laws, risking fines, legal action or imprisonment.

Service Reaction and Material Removal

Based on TikTok, the platform has removed violative content and prohibited associated hashtags and search suggestions. The organization stated it was committed to keeping the platform safe and investing in strengthening compliance measures.

Digital Trading Activities

Research also found groups with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for mixing or injecting at home.

Within minutes of joining one community, a seller shared contact information, where most transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, health issues or previous experience.

Item Details and Costs

Within these groups, messages show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When asked how long a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service said it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has previously seen individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental substance not yet authorized … may subject users to potentially serious health risks”.